Aspen Aerogels price target lowered to $25 from $27 at Barclays
The Fly

Aspen Aerogels price target lowered to $25 from $27 at Barclays

Barclays lowered the firm’s price target on Aspen Aerogels (ASPN) to $25 from $27 and keeps an Overweight rating on the shares. The company reported “another impressive quarter” and a 50% raise to its 2024 EBITDA guide provide further evidence this is one of the best new energy stories, “and it’s just getting started,” the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App